Pressure Monitoring Market Size, Share & Trends Analysis Report By Product (BP Monitors/Cardiac Pressure Monitors, Pulmonary Pressure Monitors, Intraocular Pressure Monitors, Intracranial Pressure Monitors, Others), By Applications (Hospitals, Home Care Settings), By End Use, By Region, and Segment Forecasts - 2035

Opportunity

""Connected home monitoring creates substantial opportunities for longitudinal patient management.""

Home Care Settings provide one of the strongest long-term opportunities because hypertension management depends on repeated measurements over months and years rather than occasional hospital readings. Approximately 630 million adults with hypertension worldwide are diagnosed and treated, yet only about 320 million have achieved control. This difference creates a substantial population requiring improved treatment monitoring. Connected blood pressure devices can automatically transfer measurements into smartphone applications, cloud platforms, or clinician dashboards, reducing dependence on handwritten logs. Healthcare providers can review 7-day, 30-day, or longer trends and identify persistent elevation that may not be apparent from occasional office measurements. Home monitoring can also reduce white-coat effects and provide information across different times of day. Manufacturers offering clinically validated devices with straightforward connectivity are therefore positioned to benefit as chronic disease management moves toward hybrid in-person and remote care.

Specialized pressure monitoring creates another opportunity as hospitals expand neurological, ophthalmic, cardiac, and pulmonary services. Intracranial Pressure Monitors are essential for selected traumatic brain injury, hydrocephalus, neurosurgical, and neurocritical-care patients, while Intraocular Pressure Monitors support glaucoma detection and management. Pulmonary Pressure Monitors can provide information for patients with pulmonary hypertension and selected heart-failure conditions. These categories collectively represent approximately 31% of the supplied product segmentation and provide higher technological specialization than routine blood pressure equipment. Non-invasive and minimally invasive technologies offer particular potential because they can broaden measurement beyond specialist procedures. Connected ophthalmic systems, portable tonometers, advanced hemodynamic algorithms, and remote cardiovascular platforms can extend specialist-level monitoring to additional outpatient and home environments.

Challenge

""Integrating continuous monitoring data without increasing clinical alarm burden remains difficult.""

Data volume represents an increasingly important challenge as healthcare systems deploy more continuous monitors. A device measuring pressure and other physiological parameters every few seconds can generate thousands of data points during a single hospital stay. When multiple devices create alerts independently, clinicians may experience alarm fatigue, potentially reducing responsiveness to clinically meaningful events. Manufacturers are consequently investing in configurable alarm limits, prioritization, analytics, and centralized monitoring. Some platforms provide 8 configurable patient profiles and customizable alarm settings for different clinical environments. The objective is to distinguish meaningful deterioration from transient or technically generated alerts. Achieving this balance is difficult because overly sensitive thresholds create unnecessary alarms, while excessively broad limits can delay identification of true deterioration.

Interoperability and cybersecurity create additional challenges. Pressure-monitoring information increasingly travels from bedside devices through Wi-Fi networks, central stations, electronic medical records, mobile applications, and cloud services. A hospital can operate hundreds or thousands of network-connected medical devices, creating complex integration requirements. Monitoring platforms therefore need secure communications, device authentication, software updates, access controls, and reliable network performance. Systems must also preserve monitoring during transport or temporary network disruption. Modern platforms are designed for backward and forward compatibility, but hospitals frequently operate equipment purchased across 10 or more years, making standardization difficult. Home devices add another layer because data may travel through consumer smartphones and residential internet connections before reaching healthcare providers.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

The Pressure Monitoring Market is segmented by product type into BP Monitors/Cardiac Pressure Monitors, Pulmonary Pressure Monitors, Intraocular Pressure Monitors, Intracranial Pressure Monitors, and Others, while applications comprise Hospitals and Home Care Settings. BP Monitors/Cardiac Pressure Monitors account for approximately 57% market share, followed by Intraocular Pressure Monitors at 12%, Intracranial Pressure Monitors at 10%, Pulmonary Pressure Monitors at 9%, and Others at approximately 12%. Hospitals represent approximately 72% of application demand because advanced monitoring is concentrated in institutional care, while Home Care Settings account for approximately 28%. The balance is gradually shifting as connected blood pressure measurement and remote patient management increase outside hospitals.

By Types

BP Monitors/Cardiac Pressure Monitors: BP Monitors/Cardiac Pressure Monitors dominate with approximately 57% market share because blood pressure measurement is used across preventive medicine, primary care, cardiovascular management, surgery, intensive care, emergency medicine, and home monitoring. Approximately 1.4 billion adults aged 30 to 79 years worldwide had hypertension in 2024, creating an exceptionally large monitoring population. Products range from automated upper-arm devices to ambulatory monitors and sophisticated hospital systems capable of combining non-invasive and invasive pressure measurements. Hospital platforms increasingly connect pressure information with ECG, oxygen saturation, cardiac output, respiratory measurements, and electronic medical records. Home systems emphasize simplicity, validated algorithms, automatic inflation, memory storage, and wireless synchronization with digital health applications.

Pulmonary Pressure Monitors: Pulmonary Pressure Monitors account for approximately 9% market share and are used in specialized cardiovascular and pulmonary care where clinicians need information related to pulmonary artery pressure and hemodynamic status. Pulmonary hypertension can progress over several years and may require repeated assessment to evaluate disease progression and treatment response. Hospital-based measurement can involve invasive catheterization, while implantable and remote technologies are expanding selected long-term monitoring applications. The segment benefits from growing emphasis on preventing heart-failure deterioration through earlier physiological detection. Specialized monitoring remains concentrated in advanced cardiovascular centers because interpretation requires experienced clinical teams and integration with multiple other cardiac measurements.

Intraocular Pressure Monitors: Intraocular Pressure Monitors represent approximately 12% market share and support glaucoma screening, diagnosis, treatment evaluation, and long-term ophthalmic management. Conventional tonometry provides a measurement at one clinical visit, while portable and rebound tonometers increasingly enable measurement in community, pediatric, and selected home environments. Intraocular pressure can vary throughout a 24-hour period, making longitudinal measurement increasingly relevant for patients whose office readings do not fully explain disease progression. Manufacturers including Icare Finland Oy, Essilor, and NIDEK CO., LTD. compete through portable designs, measurement speed, patient comfort, data management, and workflow integration. Aging populations are expected to increase glaucoma-related testing demand through 2035.

Intracranial Pressure Monitors: Intracranial Pressure Monitors account for approximately 10% market share and are primarily used in neurocritical care for selected patients with traumatic brain injury, hydrocephalus, intracranial hemorrhage, cerebral edema, and other neurological conditions. Normal adult intracranial pressure is generally below approximately 15 mmHg in appropriate clinical contexts, while sustained elevations can require urgent intervention. Monitoring technologies include invasive sensors and drainage-based systems capable of providing continuous information. Demand is concentrated in tertiary hospitals because installation and interpretation require neurosurgical or intensive-care expertise. Integration with multiparameter monitoring is increasingly important because clinicians evaluate intracranial pressure alongside systemic blood pressure and other physiological variables.

Others: Others represent approximately 12% market share and include pressure-monitoring technologies outside the 4 principal supplied categories. Demand is distributed across specialty clinical environments requiring measurement of physiological pressure for diagnosis, treatment, or procedural monitoring. These products increasingly connect with multiparameter systems rather than operating as completely isolated devices. Advanced hospital monitors can display more than 10 physiological waveforms simultaneously and maintain extensive trend histories, enabling clinicians to evaluate pressure changes alongside other patient information. Continued miniaturization of sensors and improvement in wireless communication are expected to support broader adoption of specialized monitoring through 2035.

By Applications

Hospitals: Hospitals hold approximately 72% market share because pressure monitoring is required across emergency departments, operating rooms, intensive care units, neurological units, cardiovascular wards, neonatal care, recovery areas, and general inpatient environments. Large hospitals can operate hundreds of bedside and transport monitors, each supporting different acuity levels. Modern systems provide non-invasive blood pressure as a standard parameter while modular configurations add invasive pressure, cardiac output, respiratory measurements, and specialty monitoring. Certain platforms can add up to 3 advanced parameters simultaneously and store approximately 72 hours of detailed monitoring data. Hospital demand is also supported by replacement cycles as older standalone equipment is replaced with networked platforms capable of electronic medical record integration.

Home Care Settings: Home Care Settings account for approximately 28% market share and are expected to gain importance as hypertension and chronic cardiovascular conditions require long-term management. Approximately 44% of adults worldwide with hypertension remain unaware of their condition, while only around 23% have controlled blood pressure. Validated home monitors enable repeated measurement without requiring frequent clinic visits. Connected devices can transmit readings to applications or remote care programs, while ambulatory monitoring platforms increasingly support 24/7 data collection. Growth is strongest for BP Monitors/Cardiac Pressure Monitors because they are comparatively easy to use without professional supervision, although portable ophthalmic and cardiovascular technologies are gradually expanding home-based specialty monitoring.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

North America

North America is estimated to account for approximately 39% of the Pressure Monitoring Market and remains the leading region because of extensive hospital infrastructure, high cardiovascular disease prevalence, established medical-device adoption, and rapid expansion of remote monitoring. The United States has more than 4 million people affected by atrial fibrillation, with the condition associated with over 750,000 hospitalizations annually. Cardiovascular risk management therefore requires extensive blood pressure, cardiac, ambulatory, and hospital monitoring. Large health systems are increasingly integrating bedside measurements with central stations and electronic records to create continuous patient information across multiple care environments.

Home monitoring is also well established across North America because patients increasingly use connected devices between physician visits. Ambulatory cardiac platforms provide near-real-time monitoring 24 hours per day and can integrate home and hospital information within one record. Wireless inpatient monitoring is expanding in parallel as hospitals seek earlier identification of deterioration while supporting patient mobility. The region also has strong adoption of advanced intracranial, pulmonary, and intraocular pressure technologies because specialized neurological, cardiovascular, and ophthalmic care is widely available. Replacement of legacy monitoring networks with interoperable systems will remain an important demand source through 2035.

Europe

Europe represents approximately 28% of market demand and maintains a mature pressure-monitoring environment supported by universal healthcare systems, aging populations, established cardiovascular screening, and sophisticated hospital infrastructure. Hypertension prevalence remains substantial across the region, creating continuing requirements for routine BP Monitors/Cardiac Pressure Monitors. European hospitals also use advanced hemodynamic systems across perioperative and intensive-care settings. In October 2025, a new patient monitor received CE marking with an integrated cardiac-output insight capability intended to support perioperative hemodynamic assessment without additional hardware for that specific functionality.

European growth is increasingly connected to care decentralization and hospital efficiency. Healthcare systems are attempting to manage larger elderly populations without proportionally increasing inpatient capacity, supporting remote and home monitoring. Ophthalmic pressure monitoring also has a strong regional technology base, particularly through Finland and other established European medical-device centers. Connected systems must comply with increasingly stringent cybersecurity and data-protection requirements, encouraging manufacturers to strengthen secure interoperability. Hospitals are expected to prioritize scalable platforms that can operate across at least 4 major care environments rather than purchasing separate monitoring architectures for each department.

Asia-Pacific

Asia-Pacific accounts for approximately 26% market share and is projected to record the fastest growth at around 4.6% annually. China, India, Japan, South Korea, Australia, and Southeast Asia contain large and aging populations together with rapidly developing hospital systems. Two-thirds of adults aged 30 to 79 years living with hypertension globally are located in low- and middle-income countries, giving Asian healthcare systems substantial screening and treatment requirements. Expansion of primary care and community screening is increasing demand for affordable automated blood pressure monitors, while tertiary hospitals are investing in advanced multiparameter monitoring.

Japan has a particularly strong medical-device manufacturing base, represented among the supplied companies by NIHON KOHDEN CORPORATION and NIDEK CO., LTD., while India and China offer substantial opportunities for affordable monitoring platforms. Hospital systems increasingly require scalable products that can serve both high-acuity and lower-acuity environments. Home Care Settings are also expanding as smartphone adoption enables connected health applications. The region's population exceeds 4 billion people, making even modest increases in hypertension screening frequency significant for device demand. Local manufacturing is likely to become increasingly important as governments seek wider access to validated pressure-monitoring technologies.

Middle East & Africa

Middle East & Africa represents approximately 7% of market demand but carries a substantial cardiovascular disease burden. The Eastern Mediterranean region has hypertension prevalence of approximately 38% among adults within the relevant age range, exceeding several other global regions. Gulf countries are investing in advanced hospitals and digital healthcare, supporting demand for multiparameter patient monitoring, invasive pressure systems, and connected cardiovascular technologies. Major urban hospitals increasingly deploy centralized monitoring networks across intensive care, operating rooms, emergency departments, and specialist units.

Africa presents a different opportunity centered on affordable blood pressure screening and primary care. Many healthcare systems have limited access to validated devices, trained personnel, and specialist pressure-monitoring technologies. Only 28% of low-income countries recently reported general availability of all recommended hypertension medicines in pharmacies or primary-care facilities, illustrating broader gaps across cardiovascular care infrastructure. Expanding access to reliable automated monitors could improve detection among populations where hypertension often remains undiagnosed. Portable devices with rechargeable batteries and simplified interfaces are particularly relevant for community programs serving locations with limited infrastructure.

List of Top Pressure Monitoring Companies

• Philips Healthcare
• Hill-Rom
• GE Healthcare
• Drägerwerk AG & Co. KGaA
• Medtronic
• BD
• Nonin Medical Inc.
• A&D Medical
• NIHON KOHDEN CORPORATION
• Smiths Medical
• Icare Finland Oy
• Essilor
• NIDEK CO., LTD.
• ICU Medical
• Merit Medical

Top 2 Companies Market Share

Philips Healthcare: Philips Healthcare is estimated to account for approximately 17% share within the supplied competitive framework, supported by broad hospital monitoring capabilities, cardiovascular technologies, connected care infrastructure, and a large installed base. Its competitive position is strengthened by the shift toward enterprise monitoring in which pressure information is combined with multiple vital signs and distributed across bedside, central, and mobile clinical interfaces. Large hospital systems increasingly seek monitoring architectures capable of supporting several acuity levels while maintaining consistent user interfaces and data continuity.

GE Healthcare: GE Healthcare is estimated to hold approximately 15% share within the analyzed competitive structure, giving the top 2 supplied companies a combined estimated share of approximately 32%. The company offers patient monitoring systems with 10-inch, 12-inch, and 15-inch display configurations, modular advanced parameters, wireless connectivity, and up to 72 hours of full-disclosure information on selected platforms. Its Carevance patient monitor received CE marking in October 2025 and introduced Cardiac Output Insights for perioperative hemodynamic assessment, illustrating the industry's movement toward algorithm-supported pressure and cardiovascular monitoring.

Investment Analysis

Investment in the Pressure Monitoring Market is increasingly directed toward connected hospital infrastructure, home monitoring, wireless sensors, interoperability, and clinical decision support. Hospitals replacing equipment are moving beyond individual bedside monitors toward networks that connect potentially hundreds of devices with central stations and electronic medical records. This creates investment requirements in hardware, software, networking, cybersecurity, analytics, and training. Modular platforms are attractive because hospitals can deploy essential blood pressure monitoring initially and add up to 3 advanced parameters as clinical requirements increase. Investments are also targeting alarm analytics because continuous monitoring generates substantially more information than periodic vital-sign collection. Manufacturers capable of reducing false alerts while preserving clinically important notifications can improve the operational value of their systems.

Home monitoring represents another attractive investment area because approximately 1.4 billion adults worldwide have hypertension while only around 320 million have achieved control. Connected devices can create recurring digital engagement by synchronizing measurements with applications and remote-care services. Asia-Pacific offers particularly strong expansion potential at approximately 4.6% annual growth within the current market framework as hospitals modernize and consumer adoption increases. Investment is also flowing into specialized pressure monitoring, including portable tonometry, neurocritical-care sensors, and hemodynamic algorithms. Companies able to combine validated measurements with secure data management are likely to gain an advantage as healthcare providers increasingly evaluate complete monitoring workflows rather than hardware specifications alone.

New Product Development

New product development is increasingly focused on transforming pressure measurements into actionable clinical information. In October 2025, a new hospital patient-monitoring platform received European regulatory clearance and incorporated Cardiac Output Insights, combining an algorithm with visual decision support for perioperative hemodynamic management. The direction is significant because future pressure monitors will increasingly provide trend interpretation and decision-support functionality rather than simply displaying systolic, diastolic, mean arterial, or invasive pressure values. Modular systems can also scale from basic vital signs to at least 3 advanced parameters, allowing one platform to serve patients with different acuity levels.

Wireless and wearable development is expanding at the same time. New monitoring solutions support continuous collection of physiological information while allowing patients to walk during recovery rather than remaining physically connected to stationary bedside systems. Mobile monitoring platforms can transmit information continuously and generate actionable alarms when patient status changes. Home product development is emphasizing automatic synchronization, multi-user memory, irregular-heartbeat detection, simplified cuffs, and long battery life. With approximately 600 million hypertensive adults unaware of their condition, manufacturers are also improving usability to encourage screening and repeated measurement among people without previous experience using medical devices.

Five Recent Developments

• October 2025: GE Healthcare announced European regulatory clearance for its Carevance patient monitor, adding Cardiac Output Insights to support perioperative hemodynamic assessment while extending scalable monitoring across multiple acute-care environments without requiring additional hardware for the feature.
• September 2025: Global hypertension initiatives increased emphasis on validated pressure-monitoring devices after updated international analysis estimated that 1.4 billion adults aged 30 to 79 years were living with hypertension and only approximately 23% had achieved control.
• June 2025: Hospital monitoring development increasingly prioritized wearable and wireless surveillance, with continuous systems combining at least 3 core physiological measurements and real-time trend transmission to help clinicians detect patient deterioration while supporting mobility during recovery.
• November 2024: Home blood pressure monitoring development accelerated around connected devices capable of storing multiple measurements and transmitting readings to digital applications, supporting longer-term hypertension management as healthcare systems increasingly adopted remote and hybrid care pathways.
• May 2024: Ophthalmic monitoring innovation continued shifting toward portable intraocular pressure measurement, supporting faster glaucoma screening and follow-up outside conventional examination rooms while increasing opportunities for handheld and rebound tonometry across specialist and community care environments.

Report Coverage

The Pressure Monitoring Market report evaluates industry conditions across the 2026-2035 forecast period using 2025 as the principal baseline. Coverage includes the supplied product types BP Monitors/Cardiac Pressure Monitors, Pulmonary Pressure Monitors, Intraocular Pressure Monitors, Intracranial Pressure Monitors, and Others, together with Hospitals and Home Care Settings. BP Monitors/Cardiac Pressure Monitors are estimated to account for approximately 57% of product demand, Intraocular Pressure Monitors 12%, Intracranial Pressure Monitors 10%, Pulmonary Pressure Monitors 9%, and Others 12%. Hospitals represent approximately 72% of application demand and Home Care Settings approximately 28%. 

The competitive assessment covers Philips Healthcare, Hill-Rom, GE Healthcare, Drägerwerk AG & Co. KGaA, Medtronic, BD, Nonin Medical Inc., A&D Medical, NIHON KOHDEN CORPORATION, Smiths Medical, Icare Finland Oy, Essilor, NIDEK CO., LTD., ICU Medical, and Merit Medical. Current industry analysis considers approximately 1.4 billion adults living with hypertension, around 600 million affected adults remaining unaware of their condition, approximately 320 million achieving blood pressure control, hospital systems storing up to 72 hours of detailed monitoring information, and modular devices capable of supporting at least 3 advanced parameters. Coverage further examines hospital monitoring, home care, cardiovascular surveillance, pulmonary pressure, intraocular pressure, intracranial pressure, wireless connectivity, wearable monitoring, clinical algorithms, interoperability, cybersecurity, investment, product development, and regional opportunities through 2035.